| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |
| 08/01/2002 | WO2002059092A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 08/01/2002 | WO2002059091A1 Process for preparation of cyanophenylbenzoic acid derivatives |
| 08/01/2002 | WO2002059090A2 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 08/01/2002 | WO2002059064A1 A recovery method |
| 08/01/2002 | WO2002058844A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002040461A3 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications |
| 08/01/2002 | WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | WO2001078697A3 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103194 Secondary amine, imine, amidine, guanidine, or other nitrogen functional group compounds; for treatment or prevention of diseases in which treatment is mediated by muscarinic receptor agonism such as cognitive decline and Alzheimer's disease |
| 08/01/2002 | US20020103191 Antitumor dibenzofluorene derivatives |
| 08/01/2002 | US20020103162 Use of threo-methylphenidate compounds to enhance memory |
| 08/01/2002 | US20020100854 Furnace mount and method of installation |
| 08/01/2002 | CA2429490A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 08/01/2002 | CA2427646A1 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 07/31/2002 | EP1227083A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS |
| 07/31/2002 | EP1226139A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP0958290B1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/31/2002 | EP0880500B1 Esters of 3-hydroxy-piperidinemethanol derivatives |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/31/2002 | CN1088477C Coloured fiber stabilized by hindered amine and ultraviolet absorbent synergistic mixture |
| 07/30/2002 | US6426365 CETP activity inhibitors |
| 07/30/2002 | CA2078039C Process for the production of lactams |
| 07/25/2002 | WO2002057236A1 Phenyl derivatives |
| 07/25/2002 | WO2002057235A1 Process for preparation of benzylpiperidine compounds |
| 07/25/2002 | WO2002057234A1 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002057232A2 Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 07/25/2002 | WO2002057230A1 Il-8 receptor antagonists |
| 07/25/2002 | WO2002057218A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 07/25/2002 | WO2002057215A2 Sodium channel modulators |
| 07/25/2002 | WO2002057214A1 Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds |
| 07/25/2002 | WO2002056745A2 Method of treating parkinson's disease |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 07/25/2002 | WO2002006229A3 Heterocyclic beta-3 adrenergic receptor agonists |
| 07/25/2002 | WO2001070222A3 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 07/25/2002 | US20020099219 Piperidine compounds and process for providing the same |
| 07/25/2002 | US20020099218 For use as a protectant against ultraviolet radiation |
| 07/25/2002 | US20020099216 Compounds useful in therapy |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099214 For prophylaxis and therapy of pruritus |
| 07/25/2002 | US20020099091 For therapy of allergies |
| 07/25/2002 | US20020099090 For therapy of allergic disorders |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099088 For therapy of allergies |
| 07/25/2002 | US20020099077 Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 07/25/2002 | US20020099076 Dementias include alzheimer's disease, Lewy Body Dementia, Vascular Dementia, Dementia in Parkinson's Disease, Fronto-Temporal Dementia, Pick's Disease and Corticobasal Degeneration |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | US20020099035 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 07/25/2002 | DE10102944A1 Production of 3-cyano-1H-indol-7-yl)-(4-(4-fluorophenethyl)piperazin-1-yl)-methanone useful as a selective 5-HT2A antagonist comprises use of an indolecarboxylic acid ester as the starting material |
| 07/25/2002 | DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases |
| 07/25/2002 | CA2435299A1 Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds |
| 07/25/2002 | CA2434934A1 Process for preparation of benzylpiperidine compounds |
| 07/25/2002 | CA2427638A1 Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 07/25/2002 | CA2425125A1 Method of treating parkinson's disease |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP0934272B1 Process for preparing an intermediate useful in the synthesis of cisapride |
| 07/24/2002 | EP0824517B1 A process for the preparation of lercanidipine hydrochloride |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | CN1360605A Thermoplastic polymer having polar group, use thereof, and unsaturated compounds having polar group |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360498A Carboxylic acid derivs. that inhibit binding of integrins to their receptors |
| 07/23/2002 | US6423717 Nervous system disorders |
| 07/23/2002 | US6423690 Antibacterial agents |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002056016A2 Method for identifying a ligand for a biological substrate |
| 07/18/2002 | WO2002055618A1 Ink-jet ink and recording material |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055497A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055495A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002020481A3 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | US20020095055 Reacting a tertiary or secondary amine with hydrogen peroxide in presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition metal oxides as a catalyst in a solvent |
| 07/18/2002 | US20020094976 Polymer stabilizers; oxygen, heat, radiation resistances; discoloration inhibition; coatings; fibers; tapes; films; papermaking; HALS; fireproofing; oxidation of a 1-allyl-substituted sterically hindered amine |
| 07/18/2002 | US20020094960 Specifically unipolar depression, treatment-refractory depression, resistant depression, anxious depression and dysthymia; 2-sulfamatomethyltetrahydropyrans and sulfamato-methylcyclohexanes, e.g. topiramate |
| 07/18/2002 | US20020094944 Alkoxy-substituted perfluorocompounds |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/17/2002 | EP1222924A1 Anticancer agents |
| 07/17/2002 | EP1222152A1 A method for preparing and screening one or more compounds |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | EP0925278B1 Cytostatic hydroxamic acid derivatives |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0766668B1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 07/17/2002 | EP0635004B1 4-diphenylmethyl piperidine derivatives and process for their preparation |
| 07/17/2002 | CN1359390A Factor VII a inhibitors |
| 07/17/2002 | CN1358713A 4-amino piperdine synthesizing and catalyst and preparation process thereof |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087736C Novel amidinonaphthyl derivative or salt thereof |
| 07/17/2002 | CN1087725C Enhancement of the effect of drugs by deuteration |